Show simple item record

dc.contributor.authorValle, Juan W
dc.contributor.authorBhatnagar, P
dc.contributor.authorYoung, E
dc.contributor.authorLevine, Edward
dc.contributor.authorSwindell, Ric
dc.contributor.authorSaunders, Mark P
dc.date.accessioned2010-03-15T16:53:57Z
dc.date.available2010-03-15T16:53:57Z
dc.date.issued2005-12
dc.identifier.citationIrinotecan with bolus and infusional 5-flurouracil and folinic acid for patients with advanced or metastatic colorectal cancer previously treated with 5-flurouracil: a possible alternative to single-agent irinotecan in a 'real-life' setting. 2005, 17 (8):666 Clin Oncolen
dc.identifier.issn0936-6555
dc.identifier.pmid16372501
dc.identifier.urihttp://hdl.handle.net/10541/94297
dc.language.isoenen
dc.subjectColorectal Canceren
dc.subjectCancer Metastasisen
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshAntineoplastic Combined Chemotherapy Protocols
dc.subject.meshCamptothecin
dc.subject.meshColorectal Neoplasms
dc.subject.meshFemale
dc.subject.meshFluorouracil
dc.subject.meshHumans
dc.subject.meshLeucovorin
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshNeoplasm Metastasis
dc.subject.meshRetrospective Studies
dc.titleIrinotecan with bolus and infusional 5-flurouracil and folinic acid for patients with advanced or metastatic colorectal cancer previously treated with 5-flurouracil: a possible alternative to single-agent irinotecan in a 'real-life' setting.en
dc.typeArticleen
dc.identifier.journalClinical Oncologyen


This item appears in the following Collection(s)

Show simple item record